Gene_set	Pathway	Overlap	P-value	Adjusted P-value	Odds Ratio	Combined Score	Genes
KEGG_2021_Human	NOD-like receptor signaling pathway	6/181	2.2716519598648245e-08	1.8854711266878042e-06	67.65428571428572	-217.27332348682836	IFNA1;IL1B;MEFV;STING1;TLR4;TNF
KEGG_2021_Human	Coronavirus disease	6/232	1.0038183269047773e-07	4.165846056654825e-06	52.04867256637168	-174.3857646205266	C3;IFNA1;IL1B;STING1;TLR4;TNF
KEGG_2021_Human	Legionellosis	4/57	4.533460591014752e-07	1.2542574301807481e-05	100.81761006289308	-216.95395722754864	C3;IL1B;TLR4;TNF
KEGG_2021_Human	Leishmaniasis	4/77	1.5346775084568718e-06	2.1229705533653394e-05	73.01369863013699	-170.21630123625883	C3;IL1B;TLR4;TNF
KEGG_2021_Human	Tuberculosis	5/180	1.1964633404245137e-06	2.1229705533653394e-05	45.10285714285714	-139.64032975632463	C3;IFNA1;IL1B;TLR4;TNF
KEGG_2021_Human	Pertussis	4/76	1.4558243895816926e-06	2.1229705533653394e-05	74.03703703703704	-172.05130589538587	C3;IL1B;TLR4;TNF
KEGG_2021_Human	Toll-like receptor signaling pathway	4/104	5.130876847568527e-06	5.1586184715942e-05	53.12	-132.3420645012429	IFNA1;IL1B;TLR4;TNF
KEGG_2021_Human	Shigellosis	5/246	5.593682680041904e-06	5.1586184715942e-05	32.477178423236516	-104.56486883037363	C3;IL1B;STING1;TLR4;TNF
KEGG_2021_Human	Chagas disease	4/102	4.7476288106462685e-06	5.1586184715942e-05	54.21768707482993	-134.5540755438832	C3;IL1B;TLR4;TNF
KEGG_2021_Human	Yersinia infection	4/137	1.5363738345825308e-05	0.00012751902827035005	39.774436090225564	-104.03256013781805	IL1B;MEFV;TLR4;TNF
KEGG_2021_Human	Malaria	3/50	2.5974439121209737e-05	0.00019143795895491898	73.13981762917933	-125.1475077148889	IL1B;TLR4;TNF
KEGG_2021_Human	Necroptosis	4/159	2.7677777198301538e-05	0.00019143795895491898	34.034408602150535	-90.91492941118791	IFNA1;IL1B;TLR4;TNF
KEGG_2021_Human	Influenza A	4/172	3.7714889820243616e-05	0.00024079506577540154	31.349206349206348	-84.54495262531024	IFNA1;IL1B;TLR4;TNF
KEGG_2021_Human	Cytosolic DNA-sensing pathway	3/63	5.21817057256637e-05	0.00030936296965929197	57.2	-103.63746645388204	IFNA1;IL1B;STING1
KEGG_2021_Human	Inflammatory bowel disease	3/65	5.7322256772471596e-05	0.0003171831541410095	55.34101382488479	-100.98537671170521	IL1B;TLR4;TNF
KEGG_2021_Human	RIG-I-like receptor signaling pathway	3/70	7.160249860764975e-05	0.0003714379615271831	51.17910447761194	-94.92366080084827	IFNA1;STING1;TNF
KEGG_2021_Human	Human immunodeficiency virus 1 infection	4/212	8.553680416035766e-05	0.00041663410598769235	25.192307692307693	-69.28980198257669	IFNA1;STING1;TLR4;TNF
KEGG_2021_Human	Lipid and atherosclerosis	4/215	9.035438443106581e-05	0.00041663410598769235	24.824644549763033	-68.34725873383007	IFNA1;IL1B;TLR4;TNF
KEGG_2021_Human	Human cytomegalovirus infection	4/225	0.00010785574304042276	0.0004711592985450047	23.671191553544496	-65.36509727839072	IFNA1;IL1B;STING1;TNF
KEGG_2021_Human	Rheumatoid arthritis	3/93	0.00016720908178540931	0.0006708057912963171	37.99047619047619	-74.4091590745228	IL1B;TLR4;TNF
KEGG_2021_Human	Herpes simplex virus 1 infection	5/498	0.00016972194719545373	0.0006708057912963171	15.365111561866126	-50.06173980977876	C3;IFNA1;IL1B;STING1;TNF
KEGG_2021_Human	Amoebiasis	3/102	0.00021994493140062025	0.0008297922411932491	34.497835497835496	-68.58379435140506	IL1B;TLR4;TNF
KEGG_2021_Human	NF-kappa B signaling pathway	3/104	0.0002329673917108638	0.0008407084135652911	33.806223479490804	-67.40758155759835	IL1B;TLR4;TNF
KEGG_2021_Human	Measles	3/139	0.0005476317685268026	0.0018938931994885255	24.99579831932773	-51.672386684351224	IFNA1;IL1B;TLR4
KEGG_2021_Human	Hepatitis B	3/162	0.000856615716023289	0.002843964177197319	21.318059299191376	-44.62403509135876	IFNA1;TLR4;TNF
KEGG_2021_Human	African trypanosomiasis	2/37	0.0008976760152685225	0.002865658048741822	57.378571428571426	-64.24352876962546	IL1B;TNF
KEGG_2021_Human	Graft-versus-host disease	2/42	0.0011566808072543669	0.0035557224815597204	50.175	-57.95352918467438	IL1B;TNF
KEGG_2021_Human	Type I diabetes mellitus	2/43	0.0012123028259538784	0.0035936119483632825	48.94512195121951	-56.84526782917664	IL1B;TNF
KEGG_2021_Human	Neutrophil extracellular trap formation	3/189	0.0013399484035926713	0.0038350247413169555	18.161290322580644	-38.30003183551744	C3;HDAC6;TLR4
KEGG_2021_Human	Pathogenic Escherichia coli infection	3/197	0.0015104299457678824	0.004178856183291142	17.394698085419734	-36.72187076283526	IL1B;TLR4;TNF
KEGG_2021_Human	Salmonella infection	3/249	0.0029568377027043165	0.007916694494337365	13.627177700348431	-28.69609856443984	IL1B;TLR4;TNF
KEGG_2021_Human	Cytokine-cytokine receptor interaction	3/295	0.004778958454651453	0.012019804598062744	11.412915851272016	-23.74866982495136	IFNA1;IL1B;TNF
KEGG_2021_Human	Complement and coagulation cascades	2/85	0.004661598778005346	0.012019804598062744	24.051204819277107	-31.541623523071053	C3;CFH
KEGG_2021_Human	Staphylococcus aureus infection	2/95	0.005791844483948442	0.013734945490506304	21.438172043010752	-28.45964210186145	C3;CFH
KEGG_2021_Human	IL-17 signaling pathway	2/94	0.005673660825135872	0.013734945490506304	21.67391304347826	-28.742216935482162	IL1B;TNF
KEGG_2021_Human	AGE-RAGE signaling pathway in diabetic complications	2/100	0.006399778215208473	0.01435625923952171	20.331632653061224	-27.120602948412195	IL1B;TNF
KEGG_2021_Human	Hematopoietic cell lineage	2/99	0.006275930773922806	0.01435625923952171	20.54381443298969	-27.37901341152302	IL1B;TNF
KEGG_2021_Human	C-type lectin receptor signaling pathway	2/104	0.006906399428166279	0.015085030329942137	19.524509803921568	-26.130280011490946	IL1B;TNF
KEGG_2021_Human	TNF signaling pathway	2/112	0.007973056255711614	0.0165440917306016	18.086363636363636	-24.33571316400054	IL1B;TNF
KEGG_2021_Human	Toxoplasmosis	2/112	0.007973056255711614	0.0165440917306016	18.086363636363636	-24.33571316400054	TLR4;TNF
KEGG_2021_Human	Osteoclast differentiation	2/127	0.010161324318032567	0.020570485814553733	15.886	-21.510038502238015	IL1B;TNF
KEGG_2021_Human	Natural killer cell mediated cytotoxicity	2/131	0.010785539693571716	0.021314280823010772	15.385658914728682	-20.853034219946885	IFNA1;TNF
KEGG_2021_Human	Systemic lupus erythematosus	2/135	0.011426598240460687	0.022055991952517142	14.915413533834586	-20.230385574789178	C3;TNF
KEGG_2021_Human	Fluid shear stress and atherosclerosis	2/139	0.012084353093672291	0.02279548424488182	14.472627737226277	-19.639406588988233	IL1B;TNF
KEGG_2021_Human	Phagosome	2/152	0.014335605230985022	0.026441227426039042	13.196666666666667	-17.909946150058477	C3;TLR4
KEGG_2021_Human	Non-alcoholic fatty liver disease	2/155	0.014879426053803059	0.02684766005360117	12.933006535947712	-17.54750234216727	IL1B;TNF
KEGG_2021_Human	Hepatitis C	2/157	0.015246968798416489	0.026925498090820607	12.762903225806452	-17.312716751580805	IFNA1;TNF
KEGG_2021_Human	Kaposi sarcoma-associated herpesvirus infection	2/193	0.02252556995474682	0.03895046471341638	10.31020942408377	-13.840129933766221	C3;IFNA1
KEGG_2021_Human	Epstein-Barr virus infection	2/202	0.024534595572492535	0.04104511484237785	9.835	-13.147442958027579	IFNA1;TNF
KEGG_2021_Human	Viral carcinogenesis	2/203	0.024762333575826773	0.04104511484237785	9.784825870646767	-13.073912909097736	C3;HDAC6
KEGG_2021_Human	Proteoglycans in cancer	2/205	0.025220492252545426	0.04104511484237785	9.685960591133005	-12.928804077098514	TLR4;TNF
KEGG_2021_Human	Asthma	1/31	0.03774052193970927	0.06023967924992056	29.77037037037037	-16.126223630092912	TNF
KEGG_2021_Human	Prion disease	2/273	0.04281158988095726	0.0670445652852727	7.192804428044281	-9.169844698845731	IL1B;TNF
KEGG_2021_Human	Allograft rejection	1/38	0.046083072411820386	0.07083138907742763	24.117117117117118	-13.560364723090352	TNF
KEGG_2021_Human	MAPK signaling pathway	2/294	0.04897898942595734	0.07391374767917198	6.657534246575342	-8.337786615237395	IL1B;TNF
KEGG_2021_Human	Type II diabetes mellitus	1/46	0.05553766478796506	0.0823147531678768	19.809876543209878	-11.46289716991079	TNF
KEGG_2021_Human	Human papillomavirus infection	2/331	0.06060431633754296	0.0882483904564222	5.880699088145897	-7.115618067766183	IFNA1;TNF
KEGG_2021_Human	Autoimmune thyroid disease	1/53	0.06374115884515756	0.09121579627841513	17.128205128205128	-10.081098986019231	IFNA1
KEGG_2021_Human	PI3K-Akt signaling pathway	2/354	0.06828569708469599	0.09606292979711471	5.480113636363637	-6.479364551821025	IFNA1;TLR4
KEGG_2021_Human	Amyotrophic lateral sclerosis	2/364	0.07172754804182349	0.0992231081245225	5.321823204419889	-6.226988268408014	HDAC6;TNF
KEGG_2021_Human	Alzheimer disease	2/369	0.07347088540357372	0.09996858177863309	5.2459128065395095	-6.1057863985118	IL1B;TNF
KEGG_2021_Human	Adipocytokine signaling pathway	1/69	0.08225170002715665	0.1083633508294286	13.071895424836601	-7.854937277937848	TNF
KEGG_2021_Human	Fc epsilon RI signaling pathway	1/68	0.0811045146521906	0.1083633508294286	13.26865671641791	-7.96724592924887	TNF
KEGG_2021_Human	Antigen processing and presentation	1/78	0.09251851170984433	0.11998494487370437	11.531024531024531	-6.958150954500108	TNF
KEGG_2021_Human	Hypertrophic cardiomyopathy	1/90	0.10604677818396174	0.133361857413164	9.961298377028713	-6.010407578745034	TNF
KEGG_2021_Human	PD-L1 expression and PD-1 checkpoint pathway in cancer	1/89	0.10492639565254669	0.133361857413164	10.075757575757576	-6.080768259179883	TLR4
KEGG_2021_Human	Inflammatory mediator regulation of TRP channels	1/98	0.11496450084552494	0.13631505100255098	9.130584192439862	-5.49346810373269	IL1B
KEGG_2021_Human	Pathways of neurodegeneration	2/475	0.11356791602477233	0.13631505100255098	4.014270613107822	-4.131104230952899	IL1B;TNF
KEGG_2021_Human	TGF-beta signaling pathway	1/94	0.11051569770952978	0.13631505100255098	9.528076463560334	-5.7422174156532195	TNF
KEGG_2021_Human	Dilated cardiomyopathy	1/96	0.11274260878642009	0.13631505100255098	9.32514619883041	-5.615549699272252	TNF
KEGG_2021_Human	Viral protein interaction with cytokine and cytokine receptor	1/100	0.11718138394436346	0.13698668827298827	8.94388327721661	-5.375723879218761	TNF
KEGG_2021_Human	T cell receptor signaling pathway	1/104	0.12160016340314761	0.14017796614529515	8.592233009708737	-5.152341092635986	TNF
KEGG_2021_Human	Th17 cell differentiation	1/107	0.1249011740201087	0.14065250913785193	8.345911949685535	-4.994589105830365	IL1B
KEGG_2021_Human	Insulin resistance	1/108	0.12599902727061665	0.14065250913785193	8.2668743509865	-4.943743954376122	TNF
KEGG_2021_Human	HIF-1 signaling pathway	1/109	0.1270956407872156	0.14065250913785193	8.189300411522634	-4.893732148578802	TLR4
KEGG_2021_Human	Sphingolipid signaling pathway	1/119	0.13799386385009413	0.15070382499418175	7.4858757062146895	-4.435243302362896	TNF
KEGG_2021_Human	Apoptosis	1/142	0.16259648475288416	0.17526634070765434	6.2466509062253746	-3.6047270952512624	TNF
KEGG_2021_Human	mTOR signaling pathway	1/154	0.17518011116339122	0.1864096054687368	5.74800290486565	-3.2620286219941206	TNF
KEGG_2021_Human	JAK-STAT signaling pathway	1/162	0.18347437883820783	0.19276422080469938	5.456866804692892	-3.0596637281364782	IFNA1
KEGG_2021_Human	Alcoholism	1/186	0.20790875456503763	0.21570533286122653	4.734534534534535	-2.5504914662503393	HDAC6
KEGG_2021_Human	Human T-cell leukemia virus 1 infection	1/219	0.24043153000367978	0.24636811099142494	4.001019367991845	-2.0240281738454993	TNF
KEGG_2021_Human	Neuroactive ligand-receptor interaction	1/341	0.3504975915199974	0.3547719523921925	2.5254901960784313	-0.9533164047874388	C3
KEGG_2021_Human	Pathways in cancer	1/531	0.4935522426966286	0.4935522426966286	1.580293501048218	-0.3089273055464	IFNA1
